Evidence map›Paper›PMID 39959194›Full record

ArticleAmerican journal of translational research2025

Body shape index: an index for early target organ damage in hypertension.

Wangjiang Wei, Ping Ding

Abstract read
In one paragraph

Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Wangjiang WeiDepartment of Cardiology, Beijing Ditan Hospital, Capital Medical University Beijing 100015, China.
Ping DingDepartment of Critical Care Medicine, No. 988 Hospital of The PLA Joint Logistic Support Force (PLAJLSF) Zhengzhou 450000, Henan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the relationship between obesity-related indices and target organ damage in hypertension, with the goal of improving damage prevention and treatment strategies.

methodsThis retrospective study included 150 hypertension cases from January 2022 to December 2023 treated at Beijing Ditan Hospital, including 72 cases of isolated hypertension, 48 with hypertension complicated by kidney damage, 47 with hypertension and left ventricular hypertrophy, and 44 with hypertension and carotid atherosclerosis. Clinical indicators and obesity-related indices were collected to analyze their correlation with target organ damage in hypertension.

resultsA Body Shape Index (ABSI) (OR: 1.003 [1.001-1.913], P=0.007), BMI (OR: 1.054 [1.005-1.694], P=0.023), and BRI (OR: 0.562 [0.287-0.934], P=0.034) were independently associated with hypertensive kidney damage. Age (OR: 1.037 [1.000-1.635], P=0.034), ABSI (OR: 0.901 [0.882-0.998], P=0.034), and blood pressure grading (OR: 1.473 [1.175-1.845], P=0.002) were independent risk factors for hypertensive left ventricular hypertrophy. ABSI (OR: 1.012 [1.001-1.623], P=0.032) and smoking history (OR: 0.892 [0.781-0.998], P=0.021) were independent risk factors for hypertensive carotid artery plaque formation.

conclusionABSI is an independent risk factor for target organ damage in hypertension.

Indexed as

hypertensionObesity-related indextarget organ injury

Identifiers

PMID39959194
PMCPMC11826200

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.